Concepedia

Publication | Open Access

Semaphorin 3F Modulates Corneal Lymphangiogenesis and Promotes Corneal Graft Survival

DOIFull Paper Access

17

Citations

29

References

2018

Year

Tristan Reuer, Ann-Charlott Schneider, Bertan Cakir, Anima Bühler, Johanna M. Walz, Thabo Lapp, Clemens Lange, Hansjürgen Agostini, Günther Schlunck, Claus Cursiefen,
Investigative Ophthalmology & Visual Science

Abstract

Sema3F is a novel mediator of corneal avascularity with potent anti-lymphangiogenic properties. Topical treatment with Sema3F eye drops may help to limit corneal vascularization and improve outcomes in high-risk keratoplasty patients.

References

YearCitations

Page 1